Overview

A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids

Status:
Completed
Trial end date:
2013-05-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to focus on potential differences in the occurrence of new-onset Diabetes Mellitus (a glucose metabolism disorder) when two different regimens of immunosuppressive treatment are compared.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Basiliximab
Immunosuppressive Agents
Methylprednisolone
Mycophenolate mofetil
Mycophenolic Acid
Prednisolone
Tacrolimus